Detailed company information
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Jul 15, 2026
Earnings Transcript for 2026 - Q1Released: Apr 22, 2026
Earnings Transcript for 2025 - Q4Released: Jan 28, 2026
Earnings Transcript for 2025 - Q3Released: Oct 21, 2025
Earnings Transcript for 2025 - Q2Released: Jul 17, 2025
Earnings Transcript for 2025 - Q1Released: Apr 22, 2025
Earnings Transcript for 2024 - Q4Released: Jan 23, 2025
Earnings Transcript for 2024 - Q3Released: Oct 17, 2024
Earnings Transcript for 2024 - Q2Released: Jul 17, 2024
Earnings Transcript for 2024 - Q1Released: Apr 18, 2024
Earnings Transcript for 2023 - Q4Released: Jan 24, 2024
Earnings Transcript for 2023 - Q3Released: Oct 18, 2023
Earnings Transcript for 2023 - Q2Released: Jul 19, 2023
Earnings Transcript for 2023 - Q1Released: Apr 19, 2023
Earnings Transcript for 2022 - Q4Released: Jan 25, 2023
Earnings Transcript for 2022 - Q3Released: Oct 19, 2022
Earnings Transcript for 2022 - Q2Released: Jul 20, 2022
Earnings Transcript for 2022 - Q1Released: Apr 20, 2022
Earnings Transcript for 2021 - Q4Released: Jan 26, 2022
Earnings Transcript for 2021 - Q3Released: Oct 20, 2021
Earnings Transcript for 2021 - Q2Released: Jul 21, 2021
Earnings Transcript for 2021 - Q1Released: Apr 21, 2021
Earnings Transcript for 2020 - Q4Released: Jan 27, 2021
Earnings Transcript for 2020 - Q3Released: Oct 28, 2020
Elevance Health describes 2026 non-recurring investments designed to accelerate durable capabilities across medical cost management, provider connectivity, member experience, and operational efficiency. Management notes that benefits should accumulate through 2027, supporting a plan to return to at least 12% adjusted EPS growth next year as these capabilities scale and embed in the business model.
Read postElevance Health outlines a cautious 2H 2026 outlook for Medicaid, keeping the full-year margin at -1.75% and signaling only incremental improvement in the back half as rate updates and cost actions mature. Exits from markets lacking sustainable economics, including a DC exit and 12–18 month plans for additional markets, are framed as portfolio discipline rather than a driver of the near-term margin.
Read postElevance Health outlines its comprehensive plan for embedding AI across clinical, operational, and administrative workflows in 2026, supported by over $1 billion in investments to enhance healthcare affordability, personalization, and operational efficiency.
Read postElevance Health updates its 2026 earnings forecast after strong Q1 results, reflecting seasonal trends and nonrecurring items influencing full-year projections.
Read postElevance Health plans to embed AI across clinical, operational, and member workflows by 2026, aiming to enhance decision-making, automate administrative tasks, and improve personalized care delivery.
Read postElevance Health has updated its 2026 earnings guidance, raising the full-year EPS estimate and clarifying the earnings baseline used for future growth projections, supported by strong Q1 2026 results.
Read post
Dafinchi
